These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginning. Dienstmann R; Salazar R; Tabernero J Am Soc Clin Oncol Educ Book; 2014; ():91-9. PubMed ID: 24857065 [TBL] [Abstract][Full Text] [Related]
24. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway. Bae JM; Kim JH; Kang GH Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298 [TBL] [Abstract][Full Text] [Related]
25. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer. Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084 [TBL] [Abstract][Full Text] [Related]
26. Early-onset colorectal cancer: a separate subset of colorectal cancer. Silla IO; Rueda D; Rodríguez Y; García JL; de la Cruz Vigo F; Perea J World J Gastroenterol; 2014 Dec; 20(46):17288-96. PubMed ID: 25516639 [TBL] [Abstract][Full Text] [Related]
27. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high. Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983 [TBL] [Abstract][Full Text] [Related]
28. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. Berg KCG; Eide PW; Eilertsen IA; Johannessen B; Bruun J; Danielsen SA; Bjørnslett M; Meza-Zepeda LA; Eknæs M; Lind GE; Myklebost O; Skotheim RI; Sveen A; Lothe RA Mol Cancer; 2017 Jul; 16(1):116. PubMed ID: 28683746 [TBL] [Abstract][Full Text] [Related]
29. Different miR-21-3p isoforms and their different features in colorectal cancer. Jiao W; Leng X; Zhou Q; Wu Y; Sun L; Tan Y; Ni H; Dong X; Shen T; Liu Y; Li J Int J Cancer; 2017 Nov; 141(10):2103-2111. PubMed ID: 28734015 [TBL] [Abstract][Full Text] [Related]
30. E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts. Wiegering A; Korb D; Thalheimer A; Kämmerer U; Allmanritter J; Matthes N; Linnebacher M; Schlegel N; Klein I; Ergün S; Germer CT; Otto C Neoplasia; 2014 Nov; 16(11):972-81. PubMed ID: 25425971 [TBL] [Abstract][Full Text] [Related]
31. Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification. Ostwald C; Linnebacher M; Weirich V; Prall F Int J Oncol; 2009 Aug; 35(2):321-7. PubMed ID: 19578746 [TBL] [Abstract][Full Text] [Related]
32. TrkC promotes colorectal cancer growth and metastasis. Kim MS; Suh KW; Hong S; Jin W Oncotarget; 2017 Jun; 8(25):41319-41333. PubMed ID: 28455963 [TBL] [Abstract][Full Text] [Related]
33. Age at onset should be a major criterion for subclassification of colorectal cancer. Perea J; Rueda D; Canal A; Rodríguez Y; Álvaro E; Osorio I; Alegre C; Rivera B; Martínez J; Benítez J; Urioste M J Mol Diagn; 2014 Jan; 16(1):116-26. PubMed ID: 24184227 [TBL] [Abstract][Full Text] [Related]
34. Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer. Lazzari L; Corti G; Picco G; Isella C; Montone M; Arcella P; Durinikova E; Zanella ER; Novara L; Barbosa F; Cassingena A; Cancelliere C; Medico E; Sartore-Bianchi A; Siena S; Garnett MJ; Bertotti A; Trusolino L; Di Nicolantonio F; Linnebacher M; Bardelli A; Arena S Clin Cancer Res; 2019 Oct; 25(20):6243-6259. PubMed ID: 31375513 [TBL] [Abstract][Full Text] [Related]
35. Associations of red and processed meat intake with major molecular pathological features of colorectal cancer. Carr PR; Jansen L; Bienert S; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M Eur J Epidemiol; 2017 May; 32(5):409-418. PubMed ID: 28646407 [TBL] [Abstract][Full Text] [Related]
36. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target. Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830 [TBL] [Abstract][Full Text] [Related]
37. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps. Messick CA; Church J; Casey G; Kalady MF Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479 [TBL] [Abstract][Full Text] [Related]
38. Molecular markers and pathway analysis of colorectal carcinoma in the Middle East. Beg S; Siraj AK; Prabhakaran S; Bu R; Al-Rasheed M; Sultana M; Qadri Z; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS Cancer; 2015 Nov; 121(21):3799-808. PubMed ID: 26218848 [TBL] [Abstract][Full Text] [Related]
39. Microsatellite Status of Primary Colorectal Cancer Predicts the Incidence of Postoperative Colorectal Neoplasms. Takiyama A; Tanaka T; Yamamoto Y; Hata K; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Nishikawa T; Otani K; Sasaki K; Watanabe T Anticancer Res; 2017 Oct; 37(10):5785-5790. PubMed ID: 28982902 [TBL] [Abstract][Full Text] [Related]
40. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications. Marginean EC; Melosky B Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]